Evidence map›Paper›PMID 26324540›Full record

ArticleThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry2016

Frontotemporal Dementia and Psychiatric Illness: Emerging Clinical and Biological Links in Gene Carriers.

Nikolas R Block, Sharon J Sha, Anna M Karydas, Jamie C Fong, Mary G De May, Bruce L Miller, Howard J Rosen

Abstract read
In one paragraph

Article in The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. No Association of Multiple Sclerosis withInternational journal of molecular sciences · 2023
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Unravelling the clinical spectrum and the role of repeat length inJournal of neurology, neurosurgery, and psychiatry · 2021
    Review
  9. Review
  10. Review
  11. Review
  12. The Neuropsychiatric Features of Behavioral Variant Frontotemporal Dementia.Advances in experimental medicine and biology · 2021
    Article
  13. Review
  14. Links Between the C9orf72 Repeat Expansion and Psychiatric Symptoms.Current neurology and neuroscience reports · 2019
    Review
  15. Article
  16. Psychiatric symptoms in preclinical behavioural-variant frontotemporal dementia inJournal of neurology, neurosurgery, and psychiatry · 2018
    Article
  17. Article
  18. Bibliography: Clinical Neuropsychiatry.Focus (American Psychiatric Publishing) · 2016
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Nikolas R BlockDepartment of Neurology, Memory and Aging Center, University of California, San Francisco, CA. Electronic address: nikolas.block@ucsf.edu.
Sharon J ShaDepartment of Neurology, Stanford Center for Memory Disorders, Stanford University, Palo Alto, CA.
Anna M KarydasDepartment of Neurology, Memory and Aging Center, University of California, San Francisco, CA.
Jamie C FongDepartment of Neurology, Memory and Aging Center, University of California, San Francisco, CA.
Mary G De MayDepartment of Neurology, Memory and Aging Center, University of California, San Francisco, CA.
Bruce L MillerDepartment of Neurology, Memory and Aging Center, University of California, San Francisco, CA.
Howard J RosenDepartment of Neurology, Memory and Aging Center, University of California, San Francisco, CA.
University of California, San Francisco · USUniversity Memory and Aging Center · USStanford University · US

Funding

TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
PrPSc SPECIFIC INTERACTION WITH NOVEL PrP-Fc FUSION PROTEINSP50AG023501 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MILLER, BRUCE L · 2004 to 2018
$27.1M
Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS)U01AG045390 · NIA · MAYO CLINIC ROCHESTER · PI BOEVE, BRADLEY F, ROSEN, HOWARD J · 2014 to 2018
$16.9M
The Frontotemporal Lobar Degeneration Neuroimaging InitiativeR01AG032306 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSEN, HOWARD J · 2009 to 2013
$10.0M
Multidisciplinary Research Fellowship in Alzheimer’s disease and Related DementiasT32AG023481 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BRUCE L MILLER, HOWARD J ROSEN · 2005 to 2026
$7.4M
Training - The Frontotemporal Lobar Degeneration Clinical Research ConsortiumU54NS092089 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BOXER, ADAM L. · 2014 to 2018
$6.4M
Multimodal Imaging in Frontotemporal DegenerationK24AG045333 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSEN, HOWARD J · 2013 to 2023
$1.9M
NIA NIH HHS AG032306NIA NIH HHS AG045333NIA NIH HHS AG045390NIA NIH HHS K24 AG045333NIA NIH HHS P01 AG019724NIA NIH HHS P01AG019724NIA NIH HHS P50 AG023501NIA NIH HHS P50AG023501NIA NIH HHS R01 AG032306NIA NIH HHS T32 AG023481NIA NIH HHS U01 AG045390NINDS NIH HHS NS092089NINDS NIH HHS U54 NS092089
6 · The paper itself

Abstract

objectiveTo describe psychiatric presentations in individuals with genetic mutations causing frontotemporal dementia (FTD).

designCase descriptions from five carriers of FTD-related gene mutations with symptoms associated with non-neurodegenerative psychiatric disease.

settingA comprehensive research program investigating genetic and non-genetic FTD at the University of California, San Francisco Memory and Aging Center.

participantsThree proband and two non-proband gene carriers. MEASUREMENTS: Medical history and neurological examination, neuropsychological testing, magnetic resonance and/or positron emission tomography imaging, and a genetic analysis to screen for dementia-related mutations. Genetic status was unknown at the time of initial evaluation.

resultsThe chosen cases are illustrative of the variety of presentations of psychiatric symptoms in FTD gene carriers. In some cases, a non-neurodegenerative psychiatric illness was diagnosed based on specific symptoms, but the diagnosis may have been inappropriate based on the overall syndrome. In other cases, symptoms closely resembling those seen in non-neurodegenerative psychiatric illness did occur, in some cases immediately preceding the development of dementia, and in other cases developing a decade prior to dementia symptoms.

conclusionsPsychiatric symptoms in FTD gene carriers can be very similar to those seen in non-neurodegenerative psychiatric illness. Psychiatric symptoms with atypical features (e.g., late-life onset, insidiously worsening course) should prompt careful assessment for neurodegenerative disease. Guidelines for such an assessment should be established.

Indexed as

HeterozygoteAgedBrainC9orf72 ProteinFemaleFrontotemporal DementiaHumansMaleMiddle AgedMutationNeuropsychological TestsPositron-Emission TomographyProteinsC9orf72 ProteinC9orf72 protein, humanProteinsC9ORF72Frontotemporal dementiapsychiatric disease

Identifiers

PMID26324540
PMCPMC4686378
OpenAlexW834951979

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.